FDA

AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads

According to the AMA, direct-to-consumer advertising of pharmaceuticals and medical devices drives up health care costs and should be banned. [More…]

By R Kennedy | Advertising . Antidepressant medication . Antipsychotic medication . Bipolar Depression . Bipolar Disorder . Depression . Direct-to-Consumer . Drug marketing . FDA . Health Industry . Mental health . News . Pharmaceutical Industry

DETAIL

Development and Regulation of Abuse-Deterrent Opioid Medications – FDA Public Meeting

The FDA is hosting a public meeting on October 30 and 31, 2014 to discuss the development, assessment, and regulation […]

By R Kennedy | Drugs . FDA . Opioids . Substance abuse

DETAIL